5月13日,京东健康发布2025年Q1业绩,收入166.45亿元(人民币),同比增长25.5%;经营盈利10.71亿元,同比增长119.8%。券商认为,京东健康业绩高增主要受惠1月以来流感带动的药品需求增加,以及京东平台因以旧换新优惠政策改善带来的用户流量。恒生医药ETF(159892)聚焦创新药产业链上中下游,覆盖阿里健康、京东健康、药师帮等互联网药店标的,近期密集发布的Q1业绩有望提振其热度。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.